the utility of saliva sampling in monitoring oxcarbazepine therapy has been assessed in 17 epileptic outpatients treated with a mean dose 22.7 mg/kg/d for 19-411 days , i.e . at steady-state .
C0069751
therapy
C0014544
epileptic